To further characterize CML cell lines, we also assessed BCR-ABL1 expression level (Figure 1c) and kinase activity, as determined by the phosphorylation status of CRKL, adaptor protein targeted by BCR-ABL1 kinase activity (Figure 1d). The gene discussed is CRKL; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.